• LAST PRICE
    4.4100
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    4.2000/ 29
  • Ask / Lots
    4.8000/ 2
  • Open / Previous Close
    0.0000 / 4.4100
  • Day Range
    ---
  • 52 Week Range
    Low 3.8900
    High 24.5950
  • Volume
    ---
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 4.45
TimeVolumeTHRD
09:32 ET8164.43
09:33 ET1454.3877
09:37 ET1004.38
09:39 ET1004.39
09:42 ET9704.45
09:44 ET10004.45
09:46 ET1004.44
09:48 ET5004.425
09:53 ET2004.42
10:04 ET2004.435
10:06 ET1004.42
10:09 ET1004.42
10:11 ET2004.44
10:13 ET1004.435
10:15 ET1004.435
10:20 ET10004.44
10:27 ET1004.46
10:31 ET1004.44
10:33 ET12794.48
10:36 ET45904.51
10:38 ET2004.54
10:40 ET2004.54
10:42 ET6004.55
10:44 ET82144.542
10:45 ET132224.6
10:47 ET10004.6
10:49 ET53474.58
10:51 ET4004.61
10:54 ET5004.63
10:56 ET7004.63
10:58 ET28024.64
11:00 ET10004.59
11:02 ET44204.54
11:03 ET1004.58
11:05 ET1004.56
11:07 ET5294.575
11:14 ET2004.59
11:16 ET1004.575
11:18 ET1004.59
11:21 ET1004.59
11:27 ET1004.5675
11:32 ET110024.52
11:34 ET6004.5388
11:36 ET13004.555
11:38 ET2004.57
11:39 ET13184.55
11:41 ET1004.545
11:43 ET1004.56
11:48 ET3004.56
11:50 ET11004.54
11:52 ET1004.53
11:56 ET5004.53
11:57 ET2004.54
11:59 ET2004.54
12:01 ET1004.54
12:03 ET4004.54
12:06 ET1004.55
12:08 ET3004.57
12:15 ET5004.53
12:26 ET1004.52
12:33 ET1004.54
12:35 ET1004.54
12:39 ET5024.53
12:42 ET10004.53
12:44 ET1004.54
12:46 ET11954.54
12:48 ET3154.555
12:50 ET1004.57
12:51 ET10004.55
01:00 ET4004.56
01:06 ET3004.56
01:08 ET3004.57
01:09 ET16324.52
01:11 ET11004.515
01:13 ET4004.51
01:15 ET8004.5
01:18 ET5004.5
01:42 ET2004.48
01:45 ET17304.4643
01:47 ET7004.49
01:56 ET1004.49
01:58 ET1004.49
02:03 ET21004.49
02:05 ET3004.5
02:07 ET20204.49
02:09 ET1004.49
02:23 ET1004.5
02:27 ET1004.48
02:32 ET6004.48
02:34 ET1004.485
02:36 ET1004.48
02:38 ET3004.48
02:39 ET24224.47
02:43 ET4004.49
02:45 ET1004.49
02:48 ET12094.49
02:50 ET10004.48
02:54 ET1004.49
02:57 ET8214.47
03:08 ET17094.435
03:14 ET1004.45
03:15 ET1004.45
03:24 ET6004.45
03:26 ET9234.44
03:28 ET1004.45
03:32 ET1004.45
03:33 ET1004.46
03:35 ET1004.44
03:37 ET3004.45
03:39 ET2004.46
03:42 ET1004.46
03:44 ET9474.44
03:46 ET2004.45
03:48 ET1004.45
03:50 ET4004.44
03:53 ET9004.42
03:55 ET4004.41
03:57 ET4004.41
04:00 ET36384.41
Data delayed at least 15 minutes.
No documents available
0 New Today
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesTHRD
Third Harmonic Bio Inc
178.8M
0.0x
---
United StatesTRVI
Trevi Therapeutics Inc
178.0M
-3.5x
---
United StatesBIVI
BioVie Inc
175.7M
-4.5x
---
United StatesOLMA
Olema Pharmaceuticals Inc
184.1M
-1.8x
---
United StatesTCRT
Alaunos Therapeutics Inc
166.7M
-3.7x
---
United StatesSPPI
Spectrum Pharmaceuticals Inc
164.6M
-1.3x
---
As of 2023-02-06

Company Information

Third Harmonic Bio, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the development of medicine for the treatment of allergic and inflammatory diseases. Its lead product candidate, THB001, is a potent and highly selective, oral small molecule wild-type KIT inhibitor in development for the treatment of mast cell-mediated inflammatory diseases. KIT is a cell surface receptor that acts as the master survival and functional regulator of mast cells. Mast cells are a part of the immune system, and dysfunctional mast cell activity has been implicated in the pathophysiology of a range of allergic and other inflammatory disorders including urticaria, asthma and gastrointestinal disorders, among others. It has completed Phase Ia clinical trial for THB001, which has demonstrated dose-dependent reductions of serum tryptase, a key biomarker of mast cell activity, which has been shown to correlate with clinical benefit in chronic urticaria patients.

Contact Information

Headquarters
1700 Montgomery Street, Suite 210SAN FRANCISCO, CA, United States 94111
Phone
209-727-2457
Fax
302-655-5049

Executives

Independent Chairman of the Board
Mark Iwicki
Chief Executive Officer, Director
Natalie Holles
Chief Financial Officer
Robert Ho
Chief Administrative Officer
Julie Person
Chief Scientific Officer
Adrian Ray

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$178.8M
Revenue (TTM)
---
Shares Outstanding
40.5M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
---
EPS
---
Book Value
$3.19
P/E Ratio
0.0x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.